https://www.pharmavoice.com/
Pharma Industry News | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry. PharmaVoice is a leading industry publication...
pharma industrynewspharmavoice
https://www.pharmavoice.com/news/pharma-biotech-life-cycle-drug-Kura/650566/
What pharma can teach biotech about the life cycle management of a drug | PharmaVoice
Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.
life cycle managementabout thepharmateachbiotech
https://www.pharmavoice.com/events/
Upcoming events | PharmaVoice
News for pharmacy pros
upcoming eventspharmavoice
https://www.pharmavoice.com/q-and-a/
Q&A | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/selfservice/article-licensing/submit/
License our articles | PharmaVoice
News for pharmacy pros
our articleslicensepharmavoice
https://www.pharmavoice.com/news/ai-pharma-scientist-drug-research-owkin/818113/
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma? | PharmaVoice
A new tool is giving researchers a “data center full of genius Ph.D. students in their pocket.”
for pharmatackledrugmeanpharmavoice
https://www.pharmavoice.com/news/rfk-peptide-pharma-drug-lilly-novo-obesity-rogan/817144/
Will RFK Jr.’s peptide push bolster the gray market for obesity drugs? | PharmaVoice
With competition fierce in the weight loss space, a potential change to how the FDA classifies peptides could increase pressure in the market even more.
rfk jrpeptidepushbolstergray
https://www.pharmavoice.com/news/jnj-plans-100b-revenue-this-year/817623/
How J&J plans to hit $100B in revenue this year | PharmaVoice
this yearplanshitrevenuepharmavoice
https://www.pharmavoice.com/news/pharmavoice100-pv100-pharma-leaders/690951/
The 2023 PharmaVoice 100 | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/news/fda-shame-game-complete-response-letters/816011/
The FDA’s shame game | PharmaVoice
The agency is becoming more open about its criticisms of pharma companies and leaders, raising new privacy concerns in the industry.
shamegamepharmavoice
https://www.pharmavoice.com/news/iran-trump-hormuz-pharma-war-shipping/816439/
How Trump’s war in Iran is scrambling pharma’s shipping options | PharmaVoice
A blockade at one of the world’s largest shipping lanes could shape the way pharma companies think about manufacturing and distribution.
war in iranshipping optionsscramblingpharmavoice
https://www.pharmavoice.com/topic/biotech-spotlight/
Biotech Spotlight | PharmaVoice
News for pharmacy pros
biotech spotlightpharmavoice
https://www.pharmavoice.com/news/trailblazers-ebrahim-delpassand-radiomedix/817050/
One doctor helped kickstart US nuclear medicine’s new wave. Now he’s refining it. | PharmaVoice
Dr. Ebrahim Delpassand, founder and CEO of RadioMedix, played a pivotal role in advancing nuclear medicine as a new-generation cancer treatment, but his work...
new waveonedoctorhelpedkickstart
https://www.pharmavoice.com/news/evommune-ipo-biotech-immunology-dupixent-ebglyss/816798/
Evommune bucked biotech IPO drought and is focused on the long game | PharmaVoice
Evommune went public late last year and is taking on stiff competition in immunology with a recent mid-stage clinical win.
the long gamebiotechipodroughtfocused
https://www.pharmavoice.com/contact/
Contact | PharmaVoice
News for pharmacy pros
pharmavoice
Sponsored https://joi.com/
NSFW Character AI Chat – AI Girlfriend Chat Without Limits | JOI Spicy
Explore AI chat models on JOI AI with virtual characters and digital celebrities. Chat, interact, and customize AI companions for immersive experiences.
https://www.pharmavoice.com/topic/biotech/
Biotech and Pharma News | PharmaVoice
The latest biotech pharma news for pharma industry professionals.
biotech and pharmanewspharmavoice
https://www.pharmavoice.com/news/mrna-beyond-infectious-cancer-moderna-nih-funding/816130/
mRNA is poised to rise beyond infectious diseases, if it’s not derailed by R&D cuts | PharmaVoice
Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.
infectious diseasesmrnapoisedrisebeyond
https://www.pharmavoice.com/library/
Whitepapers, webinars, and videos | PharmaVoice
Whitepapers, webinars, videos, PDF downloads and other resources
webinars and videoswhitepaperspharmavoice
https://www.pharmavoice.com/news/cancer-drugmakers-p53-target/817469/
Will cancer drugmakers ever conquer p53? | PharmaVoice
cancereverconquerp53pharmavoice
https://www.pharmavoice.com/advertise/
PharmaVoice Advertising Page
advertising pagepharmavoice
https://www.pharmavoice.com/topic/policy-regulation/
Pharmaceutical Policy and Regulations News | PharmaVoice
The latest pharmaceutical policy and regulations news covering pharma advertising regulations, ingredient regulation, and more for pharma industry...
policy and regulationspharmaceuticalnewspharmavoice
https://www.pharmavoice.com/news/pharma-ceo-pay-2025-lilly-pfizer-abbie-gsk-jnj/817361/
5 notable pharma CEO pay hikes in 2025 | PharmaVoice
Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.”
in 2025notablepharmaceopay
https://www.pharmavoice.com/newsletter@ittnewsletter.com
Page not found | PharmaVoice
News for pharmacy pros
page not foundpharmavoice
https://www.pharmavoice.com/topic/pharma/
Pharma Sector News | PharmaVoice
The latest pharma sector and pharma industry news and updates
sector newspharma
https://www.pharmavoice.com/news/lillys-car-t-devotion-cbers-next-top-dog/818419/
Lilly’s CAR-T devotion; CBER’s next top dog? | PharmaVoice
News for pharmacy pros
cardevotionnexttopdog
https://www.pharmavoice.com/topic/first-90-days/
First 90 Days | PharmaVoice
News for pharmacy pros
first 90 dayspharmavoice
https://www.pharmavoice.com/news/houman-hemmati-cber-director-fda-regulatory/817840/
Who is Dr. Houman Hemmati, potentially CBER’s next leader? | PharmaVoice
Where the rumored frontrunner stands on key issues like vaccines and public health policy.
who isdrnextleaderpharmavoice
https://www.pharmavoice.com/signup/?signup_location=header
PharmaVoice Newsletter Sign Up
Get the free pharma newsletter trusted by industry leaders. PharmaVoice delivers the latest pharma news affecting businesses today.
newsletter sign uppharmavoice
Sponsored https://faphouse.com/
FapHouse: Full-Length Porn Videos & XXX Movies - Download Sex Videos in Full HD and 4K
Watch full-length porn videos and XXX movies from premium producers on FapHouse. Download sex videos featuring the hottest pornstars and kinkiest models!
https://www.pharmavoice.com/news/lilly-kelonia-car-t-cancer-in-vivo/818010/
Lilly’s CAR-T Kelonia deal cements Big Pharma’s in vivo push | PharmaVoice
The pharma giant’s second CAR-T deal this year, this one worth up to $7 billion, further solidifies what the industry sees as the future of genetic medicines.
in vivocardealcementsbig
https://www.pharmavoice.com/signup/?signup_location=footer-list&signup_path=/
PharmaVoice Newsletter Sign Up
Get the free pharma newsletter trusted by industry leaders. PharmaVoice delivers the latest pharma news affecting businesses today.
newsletter sign uppharmavoice
https://www.pharmavoice.com/news/roches-dac-investment-big-pharmas-lavish-ceo-bumps/817756/
Roche’s DAC investment; Big Pharma’s lavish CEO bumps | PharmaVoice
Roche is investing in new cancer-fighting technology, and some of Big Pharma's CEOs notched some noteworthy pay hikes.
dacinvestmentbiglavishceo
Sponsored https://adultfriendfinder.com/
AdultFriendFinder – The World’s Largest Dating and Social Discovery Site
Join the Largest Community of Fun-Loving Adults - AdultFriendFinder. Discover the excitement of connecting with millions of like-minded members on...
https://www.pharmavoice.com/news/boehringer-ingelheims-confident-obesity-metabolic-liver-drug/816744/
Boehringer Ingelheim’s confident new leap in the obesity market | PharmaVoice
With weight loss candidates still in the clinic, the company has launched a health unit aimed at the flourishing therapeutic area.
in theconfidentnewleapobesity
https://www.pharmavoice.com/news/ocugen-succeed-gene-therapy-makers-pharma-drug/815914/
Can Ocugen succeed where other gene therapy makers have struggled? | PharmaVoice
The biotech aims to quickly bring three gene therapies to market, and overcome the development and commercialization challenges that have dogged the space.
gene therapysucceedmakerspharmavoice
https://www.pharmavoice.com/news/women-revolution-menopause-pharma-drug-bayer-astellas/816871/
Women have awaited a revolution in menopause. It hasn’t arrived. | PharmaVoice
Persistent barriers are still hindering drug development for a host of menopause symptoms.
womenrevolutionmenopausearrivedpharmavoice
https://www.pharmavoice.com/news/puerto-rico-biotech-manufacturing-hub-innovation-cytoimmune/757283/
Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise | PharmaVoice
Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a leading manufacturing hub.
manufacturing hubpuertoongoingjourneyinnovation
https://www.pharmavoice.com/topic/commercialization/
Pharma Commercialization News | PharmaVoice
The latest pharma commercialization news for pharma industry professionals covering drug commercialization, marketing, and launches.
pharmacommercializationnews
Sponsored https://chaturbate.com/
Chaturbate: Free Adult Webcams, Live Sex, Free Sex Chat, Exhibitionist and Pornstar Free Cams
https://www.pharmavoice.com/news/fda-need-speed-strain-biotechs-keep-up/818468/
FDA’s need for speed could strain small biotechs. Here’s how they can keep up. | PharmaVoice
In a more politically charged environment, getting drugs across the finish line is increasingly complex and uncertain.
need for speedcouldstrainsmallbiotechs
https://www.pharmavoice.com/news/serif-flagship-biotech-startup-modified-dna-mrna/818105/
Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine | PharmaVoice
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
a newseriflatestbiotechaims
https://www.pharmavoice.com/news/tariffs-trump-pharma-supreme-court-deals/816625/
Tariffs are back. What does it mean now for pharma? | PharmaVoice
While the Trump administration has again levied large new tariffs, drugmakers willing to make deals could gain some relief.
for pharmatariffsbackmeanpharmavoice
https://www.pharmavoice.com/news/big-pharma-pipeline-roche-sanofi-drug/817232/
The era of Big Pharma’s one-size-fits-all pipeline is fading | PharmaVoice
one sizeerabigfitspipeline
https://www.pharmavoice.com/press-release/
Press Releases | PharmaVoice
press releasespharmavoice
https://www.pharmavoice.com/news/gilead-end-hiv-drug-trump-pharma-funding-cut/815245/
Gilead could potentially end HIV. But will it be able to? | PharmaVoice
After launching a PrEP medication that was 100% effective in clinical trials, the company is facing a complex global rollout and leveraging its network of...
couldendhivablepharmavoice
https://www.pharmavoice.com/news/pharma-diagnostics-cleveland-cancer-drug-test/818392/
Is pharma missing the boat on diagnostics? | PharmaVoice
Precision medicine is bringing pharma and diagnostics closer together, but there’s still a ways to go before the matchup is fully realized.
pharmamissingboatdiagnostics
https://www.pharmavoice.com/topic/manufacturing/
Pharmaceutical Manufacturing | PharmaVoice
The latest pharmaceutical manufacturing and drug manufacturing news for pharma industry professionals.
pharmaceutical manufacturingpharmavoice
https://www.pharmavoice.com/selfservice/event-listings/contact
List your event | PharmaVoice
News for pharmacy pros
list your eventpharmavoice
https://www.pharmavoice.com/news/novos-fda-voucher-victory-biotechs-rigid-glass-ceiling/815860/
Novo’s FDA voucher victory; biotech’s rigid glass ceiling | PharmaVoice
While Novo Nordisk collected a win through the FDA’s new voucher program, the initiative remains unpredictable and controversial.
fdavouchervictoryrigidglass
https://www.pharmavoice.com/news/insilico-brings-ai-to-womens-health-trumps-tariff-loophole-for-pharma/817148/
Biotech’s IPO comeback; Trump’s tariff loophole for pharma | PharmaVoice
Biotech IPOs gain long-lost momentum, and pharma companies find a way around the White House’s harsh tariffs.
for pharmaipocomebacktariffloophole
https://www.pharmavoice.com/news/pv100-pharma-leaders-executives/726233/
The 2024 PharmaVoice 100 | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/topic/research-development/
Pharmaceutical Research and Development News | PharmaVoice
The latest pharmaceutical research and development news for pharma industry professionals.
research and developmentpharmaceuticalnewspharmavoice
https://www.pharmavoice.com/topic/patient/
Pharma Patient News | PharmaVoice
The latest pharma patient news and updates covering the pharma patient journey, engagement, and support.
pharmapatientnews
https://www.pharmavoice.com/news/big-pharma-food-allergies-novartis-excellergy/816135/
Big Pharma goes nuts over food allergies — again | PharmaVoice
Novartis’ acquisition of Excellergy for up to $2 billion portends a potential new wave of medicines for food allergies.
big pharmafood allergiesgoesnutspharmavoice
https://www.pharmavoice.com/?page=2
Pharma Industry News | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry. PharmaVoice is a leading industry publication...
pharma industrynewspharmavoice
https://www.pharmavoice.com/press-release/get-started/
Press Release Distribution Service | PharmaVoice
News for pharmacy pros
press release distributionservicepharmavoice
https://www.pharmavoice.com/about/
About Us | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry
uspharmavoice
https://www.pharmavoice.com/news/hhs-pharma-leaders-trumprx-pbm-drug-pricing-oz-cuban-means-ubl/818312/
HHS, industry leaders spar over drug pricing, TrumpRx and PBMs | PharmaVoice
Debate about drug costs erupted among prominent healthcare figures, including Dr. Oz, Mark Cuban, Calley Means and PhRMA in Washington, D.C., but they all...
industry leadersdrug pricinghhsspartrumprx
https://www.pharmavoice.com/opinion/
Opinion | PharmaVoice
News for pharmacy pros
opinionpharmavoice
https://www.pharmavoice.com/news/anthropic-coefficient-bio-pharma-drug-deal-nvidia/818599/
Why AI maker Anthropic’s deal with Coefficient Bio could be a pharma turning point | PharmaVoice
The large AI player is paying $400 million for the tiny startup, signaling a potential shift in how tech is approaching opportunities in drug development.
why aiturning pointmakerdealcoefficient
https://www.pharmavoice.com/topic/leadership/
Pharma Leadership News | PharmaVoice
The latest pharma leadership news covering the C-suite and executives of the top pharma companies.
pharmaleadershipnews
https://www.pharmavoice.com/news/ai-drug-discovery-pharma-immunai-pfizer-novo-nordisk-cradle/758994/
How AI advances will shape the drugmaker of the future | PharmaVoice
An AI revolution is taking place, and leaders from tech to Big Pharma are forecasting what drugmakers of the future will look like.
aiadvancesshapefuturepharmavoice
https://www.pharmavoice.com/news/ai-disease-target-pharma-drug-rd-illumina/816532/
AI’s next trick? Revealing new disease targets for drug R&D | PharmaVoice
A wave of AI-driven platforms bucks the traditional approach of hunting for new molecules and instead focuses on pinpointing the underlying cause of disease.
nexttrickrevealingnewdisease
https://www.pharmavoice.com/news/pfizer-valneva-lyme-disease-tick-vaccine/816308/
Will Pfizer’s Lyme disease gamble pay off or set the space back? | PharmaVoice
As the disease spreads into new regions, the urgency for prevention is growing.
lyme diseasethe spacegamblepayset
https://www.pharmavoice.com/editors/
Editorial Team | PharmaVoice
News for pharmacy pros
editorial teampharmavoice
https://www.pharmavoice.com/news/lsd-anxiety-definium-jnj-spravato-drug-pharma-fda/817738/
Can an LSD candidate do for anxiety what Spravato did for depression? | PharmaVoice
Definium Therapeutics is expecting late-stage data for two anxiety trials in the coming months, teeing up a potential approval.
lsdcandidateanxietyspravatodepression
https://www.pharmavoice.com/news/submit-pitches-for-pharmavoices-ongoing-series/611747/
Submit pitches for PharmaVoice’s ongoing series | PharmaVoice
Our new approach to recognizing inspiring leaders across the industry.
ongoing seriessubmitpitchespharmavoice
https://www.pharmavoice.com/news/biosimilars-traction-us-patent-thicket-scrutiny/818596/
As biosimilars gain US traction, patent thickets are under more scrutiny | PharmaVoice
A 10-year push for more biosimilars in the U.S. has led to a surge in copycat entrants, bringing more attention to the legal barriers.
biosimilarsgainustractionpatent
https://www.pharmavoice.com/profiles/
Profiles | PharmaVoice
News for pharmacy pros
profilespharmavoice
Sponsored https://xtease.com/
Xtease - Strip Cam Live & Strip Tease Shows – Hot Adult Chat
Watch the hottest strip cams and live strip tease shows on Xtease. Join now for real-time adult chat and connect instantly with your favorite teasing models.
https://www.pharmavoice.com/news/new-fda-guidance-clinical-trials-bayesian/811755/
New FDA guidance that’s a ‘huge deal’ for clinical trials | PharmaVoice
Why using Bayesian statistics could transform trial design for rare diseases and beyond.
clinical trialsnewfdaguidancepharmavoice